Pilot Clinical Study Showing Abnormal Copper Metabolism in Healthy Wilson Disease Heterozygote Subjects

Documenti analoghi

• Mass Balance and Metabolism of 14 C ‐Atogepant in Healthy Male Participants: Findings of a Phase 1 Clinical Trial
  di: Ramesh R. Boinpally, et al.
  Pubblicazione: (2025)
• Hemodynamic and Pharmacokinetic Interactions of TPN171 with Alcohol in Healthy Male Subjects
  di: Jie Cheng, et al.
  Pubblicazione: (2025)
• Ecopipam, a Dopamine D1 Receptor Antagonist: Pharmacokinetics, Mass Balance, and Metabolism in Healthy Volunteers
  di: Virginia D. Schmith, et al.
  Pubblicazione: (2026)
• A Pilot Study to Explore Length and Readability Characteristics of Subject Information Sheets/Informed Consent Forms of Clinical Trial Applications in the EU
  di: Sophie Brunner Ziegler, et al.
  Pubblicazione: (2026)
• Proteomic Identification of Plasma Biomarkers of Response to IL‐5 Inhibitor Biologics in Healthy Subjects
  di: Lakshmi Manasa S. Chekka, et al.
  Pubblicazione: (2025)